STAGE III PROSTATE CANCER AJCC V7
Clinical trials for STAGE III PROSTATE CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to halt prostate Cancer's return
Disease control CompletedThis study tested whether adding an experimental drug (MK-2206) to the standard hormone therapy bicalutamide can better control prostate cancer in men whose PSA levels are rising after initial treatment. About 108 men with recurrent prostate cancer took part. The goal was to see …
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Exercise and online therapy show promise for cancer fatigue
Symptom relief CompletedThis study tested whether exercise, with or without internet-based cognitive behavior therapy, could reduce fatigue in 126 men with advanced prostate cancer. Participants were on hormone therapy and followed a 12-week exercise program. The goal was to see if these non-drug approa…
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC